BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18408458)

  • 1. Update on viral hepatitis: 2007.
    Degertekin B; Lok AS
    Curr Opin Gastroenterol; 2008 May; 24(3):306-11. PubMed ID: 18408458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on viral hepatitis: 2008.
    Degertekin B; Lok AS
    Curr Opin Gastroenterol; 2009 May; 25(3):180-5. PubMed ID: 19387254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on viral hepatitis: 2005.
    Wong SN; Lok AS
    Curr Opin Gastroenterol; 2006 May; 22(3):241-7. PubMed ID: 16550038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on viral hepatitis: 2006.
    Tan J; Lok AS
    Curr Opin Gastroenterol; 2007 May; 23(3):263-7. PubMed ID: 17414841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telaprevir: hope on the horizon, getting closer.
    Weisberg IS; Jacobson IM
    Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of viral hepatitis].
    Vucelić B
    Acta Med Croatica; 2003; 57(3):171-81. PubMed ID: 14582463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boceprevir, an NS3 protease inhibitor of HCV.
    Berman K; Kwo PY
    Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New paradigms for the treatment of chronic hepatitis B.
    Fung J; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1182-92. PubMed ID: 18637060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin/antiviral regimen?
    Angus PW; Patterson SJ
    Liver Transpl; 2008 Oct; 14 Suppl 2():S15-22. PubMed ID: 18825721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entecavir monotherapy for lamivudine-refractory chronic hepatitis B.
    Goulis I; Dalekos GN
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):855-9. PubMed ID: 19053898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategies for chronic hepatitis B virus infection in 2008.
    Khokhar A; Afdhal NH
    Am J Med; 2008 Dec; 121(12 Suppl):S33-44. PubMed ID: 19185073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine protease inhibitors as anti-hepatitis C virus agents.
    Reiser M; Timm J
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprophylaxis of viral hepatitis: a practical guide.
    Schiff ER
    Am J Gastroenterol; 1987 Apr; 82(4):287-91. PubMed ID: 3031979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New developments in therapy and prophylaxis of viral hepatitis (author's transl)].
    Thaler H
    Acta Med Austriaca; 1981; 7(2):43-8. PubMed ID: 6163300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral therapy for hepatitis B virus associated hepatic failure.
    Wang YM; Tang YZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):17-24. PubMed ID: 19208509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established and emerging therapies for the treatment of viral hepatitis.
    Forton D; Karayiannis P
    Dig Dis; 2006; 24(1-2):160-73. PubMed ID: 16699274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.